“Multiple patients, all of whom were of African or unspecified ancestry, received positive reports, with variants misclassified as pathogenic on the basis of the understanding at the time of testing. Subsequently, all reported variants were recategorized as benign. The mutations that were most common in the general population were significantly more common among black Americans than among white Americans (P<0.001). Simulations showed that the inclusion of even small numbers of black Americans in control cohorts probably would have prevented these misclassifications. “
Recent Posts
- Jan/Feb 2023 – The Data Driven Point of View
- The Business of Labs Negatively Impacts the Potential Outcomes for Patients
- December 2022 – The Data Driven Point of View
- Congress Needs to Update FDA’s Ability to Regulate Diagnostic Tests, Cosmetics
- Disagreement in Clinical Genetics Could Determine a Mother’s Freedom
Recent Comments